Managing ICU Arrhythmias: Rapid Rate Control Strategies Using β1-Selective Agents
Please remember to click Register to gain access to the webinar join details
Software/Hardware and Internet Requirements
Review the software/hardware and internet requirements here
Learning Objectives
  • Apply evidence-based strategies for rate control in critically ill patients with new-onset atrial fibrillation using landiolol within case-based scenarios to support safe and effective ICU management.

  • Explain the pharmacologic characteristics and mechanism of action of landiolol for the short-term reduction of ventricular rate in adult patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. 

 

Target Audience

This continuing education activity is intended to meet the needs of all practitioners who care for critically ill patients, including: 

  • Multiprofessional
Type of Activity

This live activity will improve a learner’s knowledge and competence as it relates to managing ICU arrhythmias with rapid rate control strategies using β1-selective agents.

Claiming Credit

You can complete your evaluation; and claim your certificate of participation by logging in to your MySCCM account with your SCCM Customer ID and password, then clicking on the icon for the course you are enrolled in under the MyLearning tab. If needed, you can click "Forgot my password" to reset your secure password.  

This educational activity was sponsored by AOP Health. Its contents do not necessarily represent the policy of SCCM and should not be considered endorsement by the society. 

SCCM Grievance Procedures Policy

To provide due process in the evaluation and mediation of grievances concerning ACE activities, this Grievance Procedures Policy was developed. Grievances may concern, but are not limited to, the awarding of credit for individual participation and/or registration fees issues.

  • A written complaint or grievance should be submitted to the Education Department.
  • The Education Department will attempt to resolve the grievance of the complainant.
  • If the initial response is unsatisfactory to the complainant, the matter will be referred to the Chief Executive Officer (CEO)/Executive Vice President (EVP) for action.
  • If the response from the CEO/EVP is unsatisfactory to the complainant, the matter will be referred to the SCCM Executive Committee. The ruling of the Executive Committee will be final.

 

Disclosures

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been mitigated through an established conflict-of-interest resolution process and have stated that these reported relationships will not have any impact on their ability to provide unbiased content. 
 
Planners:  

Emily Highsmith PharmD, BCCCP
Clinical Pharmacy Specialist- Critical Care/Nutrition Support
University of Texas, MD Anderson Cancer Center
Houston, TX, USA
No relevant financial relationship(s) to disclose

TJ Boron MSN, RN

LearnICU Program Development Manager
Society of Crticial Care Medicine
Mount Prospect, IL 
No relevant financial relationship(s) to disclose

Faculty: 

Emily Highsmith PharmD, BCCCP
Clinical Pharmacy Specialist- Critical Care/Nutrition Support
University of Texas, MD Anderson Cancer Center
Houston, TX, USA
No relevant financial relationship(s) to disclose 

Michael Bristow MD, PhD
Director of Pharmacogenomics, CU-CVI
University of Colorado
Boulder, CO, USA
No relevant financial relationship(s) to disclose

Jean-Luc Fellahi, MD, PhD
Professor of Anesthesiology and Critical Care
Louis Pradel University Hospital
Lyon, France
No relevant financial relationship(s) to disclose

 

 

 

 

Summary
Availability:
Registration Required
Expires on Nov 14, 2025
Location:
Online Meeting
Date / Time:
Nov 13, 2025 11:00 AM - 12:00 PM CT
Credit Offered:
1 Certificate of Participation Credit
Recommended